Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (2014-2025) 1.4.2 Ex Vivo 1.4.3 In Vivo 1.5 Market by Application 1.5.1 Global Gene Therapy for CNS Disorders Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Gene Therapy for CNS Disorders Market Size 2.2 Gene Therapy for CNS Disorders Growth Trends by Regions 2.2.1 Gene Therapy for CNS Disorders Market Size by Regions (2014-2025) 2.2.2 Gene Therapy for CNS Disorders Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Gene Therapy for CNS Disorders Market Size by Manufacturers 3.1.1 Global Gene Therapy for CNS Disorders Revenue by Manufacturers (2014-2019) 3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI) 3.2 Gene Therapy for CNS Disorders Key Players Head office and Area Served 3.3 Key Players Gene Therapy for CNS Disorders Product/Solution/Service 3.4 Date of Enter into Gene Therapy for CNS Disorders Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Gene Therapy for CNS Disorders Market Size by Type (2014-2019) 4.2 Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019) 5 United States 5.1 United States Gene Therapy for CNS Disorders Market Size (2014-2019) 5.2 Gene Therapy for CNS Disorders Key Players in United States 5.3 United States Gene Therapy for CNS Disorders Market Size by Type 5.4 United States Gene Therapy for CNS Disorders Market Size by Application 6 Europe 6.1 Europe Gene Therapy for CNS Disorders Market Size (2014-2019) 6.2 Gene Therapy for CNS Disorders Key Players in Europe 6.3 Europe Gene Therapy for CNS Disorders Market Size by Type 6.4 Europe Gene Therapy for CNS Disorders Market Size by Application 7 China 7.1 China Gene Therapy for CNS Disorders Market Size (2014-2019) 7.2 Gene Therapy for CNS Disorders Key Players in China 7.3 China Gene Therapy for CNS Disorders Market Size by Type 7.4 China Gene Therapy for CNS Disorders Market Size by Application 8 Japan 8.1 Japan Gene Therapy for CNS Disorders Market Size (2014-2019) 8.2 Gene Therapy for CNS Disorders Key Players in Japan 8.3 Japan Gene Therapy for CNS Disorders Market Size by Type 8.4 Japan Gene Therapy for CNS Disorders Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Gene Therapy for CNS Disorders Market Size (2014-2019) 9.2 Gene Therapy for CNS Disorders Key Players in Southeast Asia 9.3 Southeast Asia Gene Therapy for CNS Disorders Market Size by Type 9.4 Southeast Asia Gene Therapy for CNS Disorders Market Size by Application 10 India 10.1 India Gene Therapy for CNS Disorders Market Size (2014-2019) 10.2 Gene Therapy for CNS Disorders Key Players in India 10.3 India Gene Therapy for CNS Disorders Market Size by Type 10.4 India Gene Therapy for CNS Disorders Market Size by Application 11 Central & South America 11.1 Central & South America Gene Therapy for CNS Disorders Market Size (2014-2019) 11.2 Gene Therapy for CNS Disorders Key Players in Central & South America 11.3 Central & South America Gene Therapy for CNS Disorders Market Size by Type 11.4 Central & South America Gene Therapy for CNS Disorders Market Size by Application 12 International Players Profiles 12.1 Gilead (Kite Pharma) 12.1.1 Gilead (Kite Pharma) Company Details 12.1.2 Company Description and Business Overview 12.1.3 Gene Therapy for CNS Disorders Introduction 12.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2014-2019) 12.1.5 Gilead (Kite Pharma) Recent Development 12.2 Amgen (BioVex) 12.2.1 Amgen (BioVex) Company Details 12.2.2 Company Description and Business Overview 12.2.3 Gene Therapy for CNS Disorders Introduction 12.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2014-2019) 12.2.5 Amgen (BioVex) Recent Development 12.3 Novartis 12.3.1 Novartis Company Details 12.3.2 Company Description and Business Overview 12.3.3 Gene Therapy for CNS Disorders Introduction 12.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2014-2019) 12.3.5 Novartis Recent Development 12.4 Roche (Spark Therapeutics) 12.4.1 Roche (Spark Therapeutics) Company Details 12.4.2 Company Description and Business Overview 12.4.3 Gene Therapy for CNS Disorders Introduction 12.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2014-2019) 12.4.5 Roche (Spark Therapeutics) Recent Development 12.5 Bluebird Bio 12.5.1 Bluebird Bio Company Details 12.5.2 Company Description and Business Overview 12.5.3 Gene Therapy for CNS Disorders Introduction 12.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2014-2019) 12.5.5 Bluebird Bio Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Gene Therapy for CNS Disorders Key Market Segments Table Key Players Gene Therapy for CNS Disorders Covered Table Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Type 2014-2025 Figure Ex Vivo Figures Table Key Players of Ex Vivo Figure In Vivo Figures Table Key Players of In Vivo Table Global Gene Therapy for CNS Disorders Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Others Case Studies Figure Gene Therapy for CNS Disorders Report Years Considered Table Global Gene Therapy for CNS Disorders Market Size 2014-2025 (Million US$) Figure Global Gene Therapy for CNS Disorders Market Size and Growth Rate 2014-2025 (Million US$) Table Global Gene Therapy for CNS Disorders Market Size by Regions 2014-2025 (Million US$) Table Global Gene Therapy for CNS Disorders Market Size by Regions 2014-2019 (Million US$) Table Global Gene Therapy for CNS Disorders Market Share by Regions 2014-2019 Figure Global Gene Therapy for CNS Disorders Market Share by Regions 2014-2019 Figure Global Gene Therapy for CNS Disorders Market Share by Regions 2019 Table Market Top Trends Table Global Gene Therapy for CNS Disorders Revenue by Manufacturers (2014-2019) (Million US$) Table Global Gene Therapy for CNS Disorders Market Share by Manufacturers (2014-2019) Figure Global Gene Therapy for CNS Disorders Market Share by Manufacturers in 2018 Table Global Gene Therapy for CNS Disorders Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Gene Therapy for CNS Disorders Product/Solution/Service Table Date of Enter into Gene Therapy for CNS Disorders Market Table Mergers & Acquisitions, Expansion Plans Table Global Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table Global Gene Therapy for CNS Disorders Market Size Share by Type (2014-2019) Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019) Table Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table Global Gene Therapy for CNS Disorders Market Size Share by Application (2014-2019) Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019) Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Application in 2018 Figure United States Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table United States Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table United States Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table United States Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table United States Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table United States Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table United States Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure Europe Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table Europe Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table Europe Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table Europe Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table Europe Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table Europe Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table Europe Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure China Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table China Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table China Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table China Gene Therapy for CNS Disorders Market Size by Type (2014-20189) (Million US$) Table China Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table China Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table China Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure Japan Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table Japan Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table Japan Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table Japan Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table Japan Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table Japan Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table Japan Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure Southeast Asia Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table Southeast Asia Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table Southeast Asia Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure India Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table India Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table India Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table India Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table India Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table India Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table India Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Figure Central & South America Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$) Table Central & South America Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$) Table Central & South America Key Players Gene Therapy for CNS Disorders Market Share (2018-2019) Table Central & South America Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$) Table Central & South America Gene Therapy for CNS Disorders Market Share by Type (2014-2019) Table Central & South America Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$) Table Central & South America Gene Therapy for CNS Disorders Market Share by Application (2014-2019) Table Gilead (Kite Pharma) Company Details Table Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2014-2019) (Million US$) Figure Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019) Table Gilead (Kite Pharma) Recent Development Table Amgen (BioVex) Company Details Table Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$) Figure Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019) Table Amgen (BioVex) Recent Development Table Novartis Company Details Table Novartis Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019) Table Novartis Recent Development Table Roche (Spark Therapeutics) Company Details Table Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$) Figure Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019) Table Roche (Spark Therapeutics) Recent Development Table Bluebird Bio Company Details Table Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$) Figure Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019) Table Bluebird Bio Recent Development Table Global Gene Therapy for CNS Disorders Market Size by Regions (Million US$) 2019-2025 Figure Global Gene Therapy for CNS Disorders Market Size Share by Regions (2019-2025) Figure Global Gene Therapy for CNS Disorders Market Size Share by Regions in 2025 Figure United States Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure Europe Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure China Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure Japan Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure India Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD) Table Global Gene Therapy for CNS Disorders Market Size by Product (2019-2025) (Million US$) Figure Global Gene Therapy for CNS Disorders Market Size by Product (2019-2025) Figure Global Gene Therapy for CNS Disorders Market Size by Product in 2025 Table Global Gene Therapy for CNS Disorders Market Size by Application (2019-2025) (Million US$) Figure Global Gene Therapy for CNS Disorders Market Size by Application (2019-2025) Figure Global Gene Therapy for CNS Disorders Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Gilead (Kite Pharma) Amgen (BioVex) Novartis Roche (Spark Therapeutics) Bluebird Bio